Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹1,196Cr
Rev Gr TTM
Revenue Growth TTM
21.28%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ULTRAMAR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -4.2 | 0.0 | -3.5 | -0.9 | 8.6 | 23.0 | 10.0 | 20.4 | 43.6 | 14.8 | 21.9 | 9.6 |
| 105 | 104 | 122 | 125 | 116 | 134 | 134 | 142 | 166 | 153 | 164 | 161 |
Operating Profit Operating ProfitCr |
| 16.0 | 20.6 | 16.5 | 15.5 | 14.6 | 16.5 | 16.9 | 20.2 | 14.6 | 17.2 | 16.1 | 17.6 |
Other Income Other IncomeCr | 2 | 2 | 5 | 2 | 2 | 3 | 4 | 2 | 3 | 3 | 2 | 8 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Depreciation DepreciationCr | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 7 | 7 |
| 15 | 22 | 22 | 17 | 14 | 22 | 24 | 30 | 23 | 27 | 26 | 34 |
| 4 | 6 | 5 | 4 | 3 | 6 | 6 | 7 | 6 | 6 | 6 | 7 |
|
Growth YoY PAT Growth YoY% | -14.1 | -3.3 | -20.8 | -33.2 | -0.6 | 0.0 | 8.0 | 76.6 | 56.6 | 22.1 | 3.9 | 18.6 |
| 8.8 | 12.7 | 11.8 | 8.7 | 8.0 | 10.3 | 11.6 | 12.8 | 8.7 | 10.9 | 9.9 | 13.8 |
| 3.8 | 5.7 | 5.9 | 4.4 | 3.7 | 5.7 | 6.4 | 7.8 | 5.8 | 6.9 | 6.6 | 9.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 0.7 | 59.1 | 13.5 | 0.7 | 23.9 | 11.0 |
| 230 | 233 | 407 | 456 | 467 | 577 | 645 |
Operating Profit Operating ProfitCr |
| 24.8 | 24.4 | 17.0 | 18.1 | 16.8 | 17.0 | 16.4 |
Other Income Other IncomeCr | 12 | 10 | 9 | 11 | 10 | 12 | 16 |
Interest Expense Interest ExpenseCr | 1 | 1 | 3 | 5 | 7 | 7 | 6 |
Depreciation DepreciationCr | 9 | 9 | 12 | 17 | 22 | 24 | 27 |
| 78 | 75 | 78 | 91 | 76 | 100 | 109 |
| 16 | 19 | 19 | 22 | 18 | 25 | 26 |
|
| | -10.0 | 4.5 | 18.7 | -16.8 | 30.3 | 11.5 |
| 20.3 | 18.1 | 11.9 | 12.4 | 10.3 | 10.8 | 10.8 |
| 21.2 | 19.1 | 20.0 | 23.7 | 19.7 | 25.7 | 28.6 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| 297 | 455 | 854 | 730 | 894 | 967 | 1,057 |
Current Liabilities Current LiabilitiesCr | 44 | 54 | 63 | 71 | 92 | 99 | 121 |
Non Current Liabilities Non Current LiabilitiesCr | 35 | 46 | 72 | 75 | 84 | 101 | 107 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 164 | 218 | 208 | 238 | 269 | 290 | 299 |
Non Current Assets Non Current AssetsCr | 217 | 343 | 787 | 643 | 806 | 883 | 991 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 48 | 58 | 29 | 62 | 78 | 90 |
Investing Cash Flow Investing Cash FlowCr | -39 | -20 | -63 | -55 | -51 | -42 |
Financing Cash Flow Financing Cash FlowCr | -16 | 13 | -7 | -2 | -18 | -33 |
|
Free Cash Flow Free Cash FlowCr | 6 | 15 | -39 | 1 | 15 | 38 |
| 76.7 | 103.6 | 49.9 | 89.3 | 135.6 | 119.8 |
CFO To EBITDA CFO To EBITDA% | 62.8 | 76.8 | 34.9 | 61.3 | 83.2 | 76.1 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 413 | 854 | 949 | 952 | 968 | 1,386 |
Price To Earnings Price To Earnings | 6.7 | 15.3 | 16.3 | 13.8 | 16.8 | 18.5 |
Price To Sales Price To Sales | 1.4 | 2.8 | 1.9 | 1.7 | 1.7 | 2.0 |
Price To Book Price To Book | 1.4 | 1.9 | 1.1 | 1.3 | 1.1 | 1.4 |
| 5.6 | 10.9 | 11.7 | 9.8 | 10.7 | 12.0 |
Profitability Ratios Profitability Ratios |
| 56.5 | 53.1 | 42.7 | 48.6 | 46.5 | 44.0 |
| 24.8 | 24.4 | 17.0 | 18.1 | 16.8 | 17.0 |
| 20.3 | 18.1 | 11.9 | 12.4 | 10.3 | 10.8 |
| 23.8 | 15.2 | 8.8 | 11.8 | 8.4 | 10.0 |
| 20.5 | 12.1 | 6.8 | 9.4 | 6.4 | 7.7 |
| 16.3 | 9.9 | 5.9 | 7.8 | 5.3 | 6.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Ultramarine & Pigments Limited is a diversified Indian industrial leader with a legacy in high-quality chemical manufacturing. The company operates a multi-sectoral business model spanning **Inorganic Pigments**, **Surfactants**, **IT-Enabled Services (ITeS)**, and **Renewable Energy**. With a robust manufacturing footprint in South India and an aggressive expansion strategy into specialty chemicals, the company is positioned as a key player in both domestic and export markets.
---
### **Core Business Segments & Revenue Architecture**
The company’s revenue is driven by the transfer of control of goods and services, categorized into three primary operational pillars:
| Segment | Key Products & Services | Strategic Drivers |
|:---|:---|:---|
| **Chemicals & Allied Products** | Inorganic Pigments (Ultramarine Blue, CICP), Surfactants (Alpha Olefin Sulfonates), Synthetic Detergents. | High capacity utilization and expansion into value-added specialty grades. |
| **IT Enabled Services (ITeS)** | BPO activities and digital solutions via **Lapiz Digital Services**. | Focused on international marketing to drive high-margin service exports. |
| **Renewable Energy** | Power generation via **6 Wind Turbine Generators** (**4.3 MW** capacity). | Captive consumption to offset industrial energy costs and reduce carbon footprint. |
**Performance Highlights (FY 2024-25):**
* **Pigments Revenue:** **₹175 Crores** (+29% YoY).
* **Surfactants Revenue:** **₹430 Crores** (+25% YoY).
* **Export Earnings:** **₹167.83 Crores** (against an outgo of **₹111.16 Crores**).
---
### **Strategic Manufacturing Footprint & Infrastructure**
The company operates strategically located facilities across Tamil Nadu and Andhra Pradesh, optimized for logistics and export efficiency:
* **Ranipet, Tamil Nadu:** The primary hub for surfactants and detergents, currently operating at **optimum capacity utilization**.
* **Ambattur, Tamil Nadu:** Dedicated manufacturing unit for the pigments division.
* **Naidupeta, Andhra Pradesh:** A high-growth site housing surfactants and a new specialty chemicals plant. The company holds **Plots 60 & 61** (**₹8.98 Crore** consideration) and has commenced commercial production.
* **Guindy, Chennai:** The operational headquarters for the ITeS division.
* **Future Expansion Land:** The company has secured a **99-year lease** for **32.72 acres** in **SIPCOT Industrial Park, Manapparai, Tamil Nadu** (December 2024) for future chemical projects, recognized as a **Right-of-Use (ROU) Asset** of **₹3,266.31 lakhs**.
---
### **Aggressive Capacity Expansion & Subsidiary Growth**
Growth is being channeled through two wholly-owned subsidiaries, focusing on high-barrier specialty chemicals:
**1. Ultramarine Specialty Chemicals Limited (USCL):**
* **CICP Plant:** Commissioned the balance of planned capacity in **Q3 FY 2025-26**.
* **Pigment Expansion:** Adding **1,500 MT** of capacity; **750 MT** was commissioned in FY25, with the remainder due in **FY 2025-26**.
* **Operational Synergy:** USCL pays a **3% royalty** on net sales to the parent company for technical know-how.
* **Capital Infusion:** The parent company invested **₹13 Crore** in equity and over **₹8.5 Crore** in preference shares (2023-2024) to fund these expansions.
**2. Ultramarine Fine Chemicals Limited:**
* Incorporated in FY 2022-23; currently in the pre-operational phase to support future product lines.
**Consolidated Capacity Roadmap:**
* **Pigments Debottlenecking:** **+1,200 MT** (Total: **7,200 MT**) with a **₹25 Crore** outlay approved in Nov 2024.
* **Specialty Chemicals:** A **1,800 MT** greenfield plant was commissioned on **July 27, 2023**.
* **Inorganic Pigments:** A **1,500 MT** greenfield site commissioned in FY23 has already achieved **70% utilization**.
---
### **Financial Profile & Capital Allocation**
The company maintains a strong balance sheet with a focus on long-term value creation and consistent shareholder returns.
**Consolidated Financial Summary:**
| Metric (₹ in Crore) | FY 2023-24 | FY 2022-23 | FY 2021-22 |
| :--- | :---: | :---: | :---: |
| **Revenue from Operations** | **526** | **541** | 492 |
| **Net Profit After Tax (PAT)** | **57.60** | **69.20** | 60.17 |
| **Export Revenue** | **131** | **151** | 117 |
| **Dividend per Share (Par ₹2)** | **₹6.00 (Proposed)** | **₹5.00** | ₹5.00 |
**Key Financial Developments:**
* **Credit Ratings:** Reaffirmed by ICRA (Oct 2025) at **[ICRA] A+ (Stable)** for long-term and **[ICRA] A1+** for short-term facilities.
* **Strategic Investment:** Holds **2,04,51,770 shares** in **Thirumalai Chemicals Limited (TCL)**. In Dec 2025, the company increased its stake to **78.23%** via a **₹45 Crore** preferential allotment at **₹296 per share**.
* **Exceptional Gains:** Recorded a net gain of **₹4.26 Crore** in Dec 2025, primarily from **₹6.01 Crore** in NHAI compensation for land acquisition at Ranipet.
* **Debt Management:** Term loans (secured by Naidupet/Menakur assets) carry interest rates of **7%–8%**. Repayments for major loans began in **June 2024** and **August 2025**.
---
### **Sustainability, R&D, and ESG Integration**
Ultramarine & Pigments is transitioning toward a low-carbon, innovation-led operational model.
* **Energy Transition:** **55%** of total energy consumption is met through renewable sources. A new **750 KW** windmill is being added in **FY 2025-26**.
* **Emission Reduction:** Boilers and process heating have transitioned to **Natural Gas** to lower **Scope 1 emissions**.
* **Research & Development:** Invested **₹2.32 Crores** in FY 2024-25. Successfully commercialized **one new product** in FY25 with a pipeline of value-added grades.
* **Social Responsibility:** Expanding community healthcare infrastructure to a **200-bed** facility (**96,000 sq. ft.**) over the next **3-5 years**, including specialized dialysis and surgical units.
---
### **Risk Management & Governance**
The company employs a structured **Enterprise Risk Management (ERM)** framework to navigate market and regulatory volatility.
* **Regulatory Impact:** Recognized a one-time cost of **₹1.74 Crore** in March 2026 to comply with the **New Labour Codes** (effective Nov 2025).
* **Market Volatility:** Exposure to **USD** and **GBP** fluctuations due to imports of **Alpha Olefin (AO)** and **Lauryl Ethoxylated Oxide (LEO)**.
* **Credit Concentration:** While historically low, credit risk increased in FY24, with **one customer** accounting for **25.04%** of total receivables.
* **Compliance:** Adheres to **ISO 50001:2018**, **Responsible Care**, and **RSPO** standards. A robust **Whistle Blower Policy** and **Vigil Mechanism** are in place to ensure ethical governance.